Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed that dermatological patients using certain immunosuppressants, like azathioprine and high-dose prednisolone, had a reduced humoral immune response to the Sinovac-CoronaVac COVID-19 vaccine compared to those without such treatments.

In this study, body dysmorphic disorder symptoms in dermatological patients were strongly linked to psychiatric issues and reduced quality of life, particularly among those with unclassified dermatoses.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

This study resulted in a draft version of the Patient‐Reported Impact of Dermatological Diseases measure, PRIDD, which includes 27 items refined from patient consensus and is now undergoing psychometric testing.

In this study, a Delphi survey among 441 European dermatology patients identified psychological impacts as the most significant issues affecting their lives, underscoring the need for psychological support in managing dermatological diseases.

This study found that 69.89% of patients with metabolic syndrome attending primary healthcare in Gurupi, Brazil, exhibited dermatological manifestations, with morbid obesity strongly linked to these skin changes.

In this cross-sectional study of COVID-19 positive patients in Bangladesh, researchers found that maculo-papular eruptions were the most common dermatological manifestation, with other prevalent conditions including chilblain-like eruptions, urticarial lesions, and petechiae/purpura.

In this study, the most common skin abnormality among Iraqi COVID-19 patients was hair loss, particularly affecting younger females, while other manifestations appeared mostly in the active phase of the infection.

This review discusses the challenge of linking cutaneous manifestations directly to COVID-19 infection and highlights the inadequate characterization of these skin lesions, reporting no new clinical results.

This study evaluated the prevalence and pattern of skin disorders in patients with chronic kidney disease, observing various dermatological issues that may impact quality of life and suggesting treatments to reduce morbidity.

This review discusses the dermatologic symptoms associated with severe eating disorders like anorexia nervosa and bulimia nervosa and how they can aid in early diagnosis, without reporting new results.

This review discusses the dermatologic issues faced by transgender patients, including impacts of hormonal therapy on skin, but reports no new clinical findings.

This article provides a detailed analysis of immunosuppressive medications in transplant patients and discusses the increased risk of skin cancer, but it reports no new experimental results.

This study systematically reviewed dermatological conditions affecting transgender and gender-diverse individuals, highlighting that testosterone therapy can induce acne in 25–88% of transgender men and alopecia after over two years, while dermatologic care must consider both medical and social complexities.

In this study, xerosis and pruritus were common skin issues in pediatric chronic kidney disease patients, with xerosis linked to lower hemodialysis efficacy and higher white blood cells, and pruritis associated with higher hemoglobin levels.

This article highlights that in Australia, transgender and gender-diverse patients experience specific dermatological challenges during gender-affirming treatments, such as acne and patterned hair loss. It emphasizes the need for tailored dermatological care and guidance for these patients.

This review discusses dermatologic issues specific to transgender patients undergoing hormonal therapy and offers guidance for dermatology providers, but does not report new clinical results.

This review discusses dermatologic changes in chronic renal failure patients undergoing hemodialysis and reports no new clinical results.

This article discusses the teratogenic risks of skin condition treatments for individuals with DSD and notes that testosterone replacement, often used in this population, may cause acne.

In this study, researchers observed that patients with COVID-19 can develop a variety of skin lesions, with maculopapular rash, telogen effluvium, and urticaria showing significant associations with both the timing of symptom onset and the severity of the disease.

In this study, researchers found that hirsutism in Egyptian women with PCOS was associated with higher testosterone levels, while acne and androgenetic alopecia did not correlate with androgen levels or insulin resistance.

This review discusses the unique dermatologic needs of transgender individuals during transitioning and emphasizes the importance of accommodating care in medical settings; it reports no new clinical results.

This study analyzed 19 clinical trials and found that dermatologic adverse events, such as rash, xerosis, and mucositis, frequently occur in pediatric patients receiving targeted anticancer therapies.

Spironolactone can safely lower blood pressure in patients on other blood pressure medications, but may slightly increase the risk of low blood pressure.

In this study, researchers found that cutaneous hyperpigmentation is a primary dermatological manifestation in patients with Graves' disease, with certain treatments like carbimazole and propranolol being statistically associated with skin symptoms.

In this study, fungal infections and seborrheic dermatitis were identified as the most common skin conditions among spinal cord injury patients referred to dermatology, impacting quality of life.

This study aimed to characterize the dermatological findings in patients with end-stage renal disease undergoing maintenance hemodialysis and explore their relationship with demographic and clinical features, although specific results are not reported in the abstract.

Among 255 subjects with diabetes, this study found an 88.4% prevalence of skin conditions and 15.7% prevalence of nail manifestations, linked with factors like age and disease duration.

This review examines changes in hair physiology and treatment options for transgender patients on hormonal therapy but reports no new clinical findings, offering treatment recommendations based on the authors' experiences.

This study observed that chronic kidney disease patients undergoing hemodialysis frequently experience dermatologic manifestations, with xerosis and white nail being the most common skin and nail changes noted in 74% and 56% of patients, respectively.